News


Resident News

Glympse Bio Announces $46.7 Million Series B Financing

By JLABS

Read full story
Resident News

Versatope in Collaboration to Develop Universal Flu Vaccine

By JLABS

Read full story
Resident News

Kymera Therapeutics And Sanofi Enter Into Strategic Partnership To Advance Novel Protein Degrader Therapies To Patients

By JLABS

Read full story
Resident News

Glyscend Therapeutics Completes $20.5M Financing Round to Advance Novel Oral Polymer Therapy for Type 2 Diabetes

By JLABS

Read full story
Resident News

SpaceX Demo-2 Astronauts Get to Work on Space Station Science - Cam Med, Inc Project

By JLABS

Read full story
Resident News

Immunoscape studying immune response to Covid-19

By JLABS

Read full story
Resident News

Alumni Dragonfly Therapeutics Announces Multi-Target Expansion of its Collaboration with Merck to Use Dragonfly's Proprietary TriNKET™ Platform to Develop Novel Therapeutic Candidates in the fields of Oncology, Infectious Disease, and Immune Disorders

By JLABS

Read full story
Resident News

JLABS Alumni Kymera Therapeutics Announces $102 Million Series C Financing to Advance its Protein Degrader Pipeline and Platform

By JLABS

Read full story
Other news

Want to know more about the JLABS Portfolio?

By JLABS

Read full story
Other news

Obsidian Therapeutics Announces $49.5 Million Series A Financing to Develop Controllable Cell and Gene Therapy Products

By JLABS

Read full story